Trends of testing for and diagnosis of a1 -antitrypsin deficiency in the UK: more testing is needed Source: Eur Respir J, 52 (1) 1800360; 10.1183/13993003.00360-2018 Year: 2018
Influenza point-of-care testing: what is the point? Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
Human models of IH: what can they add? Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases Year: 2019
Single Slide Assessment: the future of molecular testing in lung cancer? Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Case detection of α1-antitrypsin deficiency: does it help the patient or the doctor? Source: Eur Respir J 2005; 26: 561-562 Year: 2005
New methods: what do they tell us? Fluctuation analysis of lung function Source: Eur Respir Mon; 2010: 47: 310–324 Year: 2010
Reply: Fixed breathing protocols in multiple-breath-washout testing: truly an option in children? Source: Eur Respir J, 57 (3) 2100189; 10.1183/13993003.00189-2021 Year: 2021
Rapid, reliable and responsive: for whom? Source: Eur Respir J 2004; 23: 1-2 Year: 2004
Phenotyping SDB: why doesn't everyone get sick? Source: International Congress 2014 – Current controversies in sleep-disordered breathing (SDB) Year: 2014
Fixed breathing protocols in multiple-breath-washout testing: truly an option in children? Source: Eur Respir J, 57 (3) 2100001; 10.1183/13993003.00001-2021 Year: 2021
Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Exercise testing: why, which and how to interpret Source: ISSN=ISSN 1810-6838, ISBN=, page=120 Year: 2004
When will genetic testing replace standard drug susceptibility testing? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018
COVID-19 phenotypes: leading or misleading? Source: Eur Respir J, 56 (2) 2002195; 10.1183/13993003.02195-2020 Year: 2020
Blood biomarkers: ready for practice? Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018
Metabolic profiling of severe asthma: implications for phenotyping and treatment Source: ERS Lung Science Conference 2020 Year: 2020
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Clustering in asthma: why, how and for how long? Source: Eur Respir J 2013; 41: 1247-1248 Year: 2013
Asthma control test: how? And where? Source: Annual Congress 2008 - Asthma control or asthma severity Year: 2008